The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Annual General Meeting

28 Jul 2023 14:58

RNS Number : 6128H
Science in Sport PLC
28 July 2023
 

28 July 2023

Science in Sport plc

("Science in Sport", "the Company" or the "Group")

 

Result of Annual General Meeting

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the active lifestyle community, held its Annual General Meeting (AGM) at 11.00 am today. All Resolutions, with the exception of Resolutions 8 and 9, as set out in the Notice of Meeting dated 5 July 2023, were duly passed. The Company also recognises that a large proportion of the votes were cast against Resolutions 1 and 7. The Board will engage in discussions with certain of its major shareholders to better understand their views. 

The table below shows the proxy position for all Resolutions:

RESOLUTIONS

FOR

 

AGAINST

 

WITHHELD

 

 

Total votes cast:

 

No. of votes

%

No. of votes

%

No. of votes

Resolution 1 To receive the accounts of the Company for the year ended 31 December 2022 and the reports of the Directors and auditors thereon (ordinary resolution).

58,811,072

 

55.16

 

47,803,350

44.84

10,978,963

Resolution 3

To elect Daniel Lampard as a director of the Company (ordinary resolution).

116,950,260

99.46

634,664

0.54

8,461

Resolution 4

To elect Henry Turcan as a director of the Company (ordinary resolution).

116,916,785

99.43

668,139

0.57

8,461

Resolution 5

To re-appoint BDO LLP as auditors of the Company (ordinary resolution).

117,584,857

99.99

8,067

0.01

461

Resolution 6

To authorise the Directors to agree the auditors' remuneration (ordinary resolution).

117,584,857

99.99

8,528

0.01

0

Resolution 7

To authorise the directors to allot shares up to the limits set out in the notice of meeting (ordinary resolution).

78,248,673

66.54

39,344,251

33.46

461

Resolution 8

That subject to the passing of resolution 7, to authorise the Directors to allot

equity securities for cash on a non pre-emptive basis (special resolution).

70,527,023

59.98

47,065,836

40.02

526

Resolution 9

That, subject to the passing of resolution 7, to authorise the Directors to allot equity securities for cash for specified capital investment purposes (special resolution).

69,422,448

59.04

48,170,411

40.96

526

 

Note: the resolution to reappoint Tim Wright as a Non-Executive Director of the Company (Resolution 2) was withdrawn prior to the AGM following his resignation from the Company on 28 July.

Note: the 'For' votes include those giving the Chairman discretion. 

Note: the full text of each of the resolutions is contained in the Notice of Annual General Meeting which is available on the Company's website at https://www.sisplc.com/results-centre/

For further information please contact:

For further information:

Science in Sport plc

T: 020 7400 3700

Stephen Moon, CEO

Daniel Lampard, CFO

 

Liberum (Nominated Adviser and Broker)

T: 020 3100 2000

Richard Lindley

Anake Singh

 

Notes to Editors

About Science in Sport plc

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, sports nutrition market, worth $24.6bn in 2022 and forecast to grow CAGR 5.9% from 2022 to 2027.1

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading endurance and strength athlete Ross Edgley and influencer Gabby Allen. 

SiS, a leading endurance nutrition business founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official endurance nutrition supplier to over 320 professional teams, organisations, and national teams worldwide. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA. 

SiS is Performance Solutions partner to Ineos Grenadiers cycling team, and Tottenham Hotspur and CGC Nice football clubs, as well as Official Nutrition Partner to the Milwaukee Bucks, 2021 National Basketball Association Champions. 

For further information, please visit phd.com and scienceinsport.com

Euromonitor Passport Database Global Assessment (October 2022)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKFBPNBKDAOB
Date   Source Headline
18th Jan 20184:41 pmRNSIssue of Equity
18th Jan 20187:00 amRNSSiS becomes Official Partner of Manchester United
17th Jan 20183:44 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSPre-Close Trading Update
6th Dec 20174:47 pmRNSHolding(s) in Company
6th Dec 201710:29 amRNSHolding(s) in Company
6th Dec 201710:27 amRNSHolding(s) in Company
6th Dec 201710:20 amRNSHolding(s) in Company
5th Dec 20177:00 amRNSHolding(s) in Company
4th Dec 20171:22 pmRNSDirector/PDMR Shareholding
1st Dec 201712:44 pmRNSResults of General Meeting and Open Offer
14th Nov 20177:00 amRNSFirm Placing and Open Offer
27th Oct 20177:00 amRNSSiS announces partnership with Rock 'n' Roll
27th Oct 20177:00 amRNSSiS announces three-year deal with USA Triathlon
20th Sep 20179:06 amRNSHalf-year Report - Replacement
20th Sep 20177:00 amRNSHalf-year Report
12th Sep 20172:43 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSTHREE MORE YEARS FOR SiS AND TEAM SKY
4th Aug 20177:00 amRNSSIS to fuel leading British football clubs
3rd Aug 20177:00 amRNSNotice of Results
20th Jul 20177:00 amRNSHalf Year Trading Update
26th Jun 20174:30 pmEQSCavendish Asset Management: Paul Mumford named Small Cap Awards' Fund Manager of the Year
26th Jun 201712:29 pmRNSDirector/PDMR Shareholding
21st Jun 201712:44 pmRNSResult of AGM
20th Jun 20178:00 amRNSPDMR Dealing
15th Jun 20177:00 amRNSSIS to fuel British Triathlon
30th May 20177:00 amRNSSIS granted patent for novel WHEY20
19th May 20175:17 pmRNSPosting of Annual Report
18th May 20177:00 amRNSSIS to Fuel Cycling Australia To Tokyo 2020
12th May 20179:00 amRNSHolding(s) in Company
3rd May 20179:23 amRNSHolding(s) in Company
23rd Mar 20171:00 pmRNSPDMR Dealings and Issue of Equity
23rd Mar 20177:00 amRNSFinal Results
2nd Mar 20179:15 amRNSTotal Voting Rights
19th Jan 20178:44 amRNSHolding(s) in Company
17th Jan 20177:00 amRNSSIS Extends World Class Banned Substance Testing
10th Jan 20177:00 amRNSSIS To Fuel British Cycling To Tokyo 2020
9th Jan 20175:24 pmRNSIssue of Equity
5th Jan 20177:00 amRNSPre-Close Trading Update
29th Nov 20167:00 amRNSSiS receives award from Investors in People
17th Nov 20167:00 amRNSDirector/PDMR Shareholding
16th Nov 20167:00 amRNSDirector/PDMR Shareholding
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
18th Oct 20167:00 amRNSAppointment of US Country Manager
26th Sep 20164:09 pmRNSNew Long Term Incentive Plan
22nd Sep 20167:00 amRNSHalf Yearly Report
21st Sep 20162:45 pmRNSAppointment of Non-Executive Director
1st Sep 20167:00 amRNSTwo New Senior Appointments
30th Aug 20167:00 amRNSOfficial Sports Nutrition Partner to Liverpool FC
25th Aug 20162:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.